Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Oct 17, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Envoy Medical, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 15
| |||||||
Anzu Special Acquisition Corp I
|
0
|
—
|
—
|
—
|
0
| ||||||||
Heart Test Laboratories, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 20
| |||||||
Heart Test Laboratories, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Endra Life Sciences Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Content Checked Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Sionix Corp
| 2.25M |
—
|
—
| +70.42% | 5.44M | +1 |
Apr 27
| ||||||
Sionix Corp
| 6.76M |
$0.04 | $106,000.00 | +986.71% | 7.44M | +1 |
Sep 30 - Apr 27
| ||||||
Sionix Corp
|
0
|
—
|
—
|
—
|
0
| +1 |
Apr 1 - Jul 1
| ||||||
Sionix Corp
| 20.83K |
$0.05 | $999.98 | +3.14% | 685.09K | +1 |
Jan 3
| ||||||
Sionix Corp
|
0
|
—
|
—
|
—
|
0
| +1 |
Apr 1 - Jul 1
| ||||||
Sionix Corp
|
0
|
—
|
—
|
—
|
0
| +1 |
Jan 1
| ||||||
Sionix Corp
| 20.83K |
$0.05 | $999.98 | +5.20% | 421.72K | +1 |
Jan 3
| ||||||
Sionix Corp
| 22.22K |
$0.05 | $999.99 | +5.87% | 400.89K | +1 |
Dec 15
| ||||||
Sionix Corp
| 16.67K |
$0.06 | $999.96 | +4.60% | 378.66K | +1 |
Dec 1
| ||||||
Sionix Corp
| 15.39K |
$0.07 | $1,000.09 | +4.44% | 362K | +1 |
Nov 15
| ||||||
Sionix Corp
| 10.36K |
$0.31 | $10,957.97 | +3.08% | 346.61K | +1 |
Mar 29 - Nov 1
| ||||||
Sionix Corp
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Sionix Corp
| 60.36K |
$0.31 | $10,957.97 |
∞
| 35.36K | +1 |
Mar 29 - Nov 1
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||